SAVA (Cassava Sciences, Inc.) Stock Financials & Earnings | Market Cap Arena

SAVA (Cassava Sciences, Inc.) Stock Financials & Earnings | Market Cap Arena

SAVACassava Sciences, Inc.

Mkt Cap$116M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$106M

EPS (TTM)-$2.19

Free Cash Flow (TTM)-$84M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q4 22	$0	-$18M	-$21M
Q1 23	$0	-$22M	-$27M
Q2 23	$0	-$392K	-$29M
Q3 23	$0	-$24M	-$28M
Q4 23	$0	-$19M	-$23M
Q1 24	$0	-$16M	-$20M
Q2 24	$0	-$15M	-$61M
Q3 24	$0	-$18M	-$31M
Q4 24	$0	-$21M	-$29M
Q1 25	$0	-$14M	-$25M
Q2 25	$0	-$5M	-$45M
Q3 25	$0	-$200K	-$12M

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 22	-$21M	-$21M
Q1 23	-$13M	-$14M
Q2 23	-$20M	-$20M
Q3 23	-$27M	-$27M
Q4 23	-$22M	-$22M
Q1 24	-$19M	-$19M
Q2 24	-$18M	-$18M
Q3 24	-$18M	-$18M
Q4 24	-$61M	-$61M
Q1 25	-$11M	-$11M
Q2 25	-$5M	-$5M
Q3 25	-$6M	-$6M

Capital Expenditures

CapEx

Quarter	CapEx
Q4 22	$335K
Q1 23	$357K
Q2 23	$6K
Q3 23	$22K
Q4 23	$41K
Q1 24	$0
Q2 24	$29K
Q3 24	$17K
Q4 24	$57K
Q1 25	$0
Q2 25	$0
Q3 25	$80K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 22	—	+45.0%
Q1 23	—	+48.8%
Q2 23	—	+44.5%
Q3 23	—	+30.6%
Q4 23	—	+8.8%
Q1 24	—	-24.8%
Q2 24	—	+113.4%
Q3 24	—	+9.8%
Q4 24	—	+29.4%
Q1 25	—	+23.3%
Q2 25	—	-26.1%
Q3 25	—	-61.3%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 22	$616K	—
Q1 23	$673K	—
Q2 23	$835K	—
Q3 23	$949K	—
Q4 23	$2M	—
Q1 24	$2M	—
Q2 24	$0	—
Q3 24	$6M	—
Q4 24	$6M	—
Q1 25	$5M	—
Q2 25	$5M	—
Q3 25	$4M	—

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q4 22	$19M	$3M	—
Q1 23	$22M	$4M	—
Q2 23	$25M	$4M	—
Q3 23	$24M	$4M	—
Q4 23	$19M	$4M	—
Q1 24	$16M	$7M	—
Q2 24	$15M	$52M	—
Q3 24	$18M	$14M	—
Q4 24	$21M	$943K	—
Q1 25	$14M	$8M	—
Q2 25	$5M	$9M	—
Q3 25	$4M	—	$8M

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$201M	$0	$201M
Q1 23	$187M	$0	$187M
Q2 23	$168M	$0	$168M
Q3 23	$142M	$0	$142M
Q4 23	$121M	$0	$121M
Q1 24	$124M	$0	$124M
Q2 24	$207M	$0	$207M
Q3 24	$149M	$0	$149M
Q4 24	$129M	$0	$129M
Q1 25	$117M	$0	$117M
Q2 25	$112M	$0	$112M
Q3 25	$106M	$0	$106M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q4 22	41M	+1.8%
Q1 23	42M	+2.4%
Q2 23	42M	+0.1%
Q3 23	42M	+0.5%
Q4 23	42M	+0.4%
Q1 24	44M	+4.5%
Q2 24	46M	+4.8%
Q3 24	48M	+3.8%
Q4 24	48M	+0.3%
Q1 25	48M	+0.3%
Q2 25	48M	+0.1%
Q3 25	48M	-0.0%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 13	$5M	8
FY 14	$0	9
FY 15	$0	8
FY 16	$0	9
FY 17	$0	9
FY 18	$0	9
FY 19	$0	9
FY 20	$0	11
FY 21	$0	24
FY 22	$0	26
FY 23	$0	29
FY 24	$0	30